Fernández-Ruiz, Irene <br/><br/>
Pharmacogenetics: Genetic approach supports cardiovascular safety of GLP1R agonists.  [electronic resource] 

 -  Nature reviews. Cardiology  08 2016 
 - 444 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1759-5010 
<br/><br/><label>Standard No.: </label>10.1038/nrcardio.2016.100  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Coronary Disease--chemically induced<br/>Glucagon-Like Peptide-1 Receptor--genetics<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Pharmacogenetics<br/>Pharmacogenomic Variants<br/>Protective Factors<br/>Risk Assessment<br/>Risk Factors<br/>Glucagon-Like Peptide-1 Receptor Agonists